Harnessing virus tropism for dendritic cells for vaccine design

Curr Opin Virol. 2020 Oct:44:73-80. doi: 10.1016/j.coviro.2020.07.012. Epub 2020 Aug 6.

Abstract

Dendritic cells (DCs) are pivotal stimulators of T cell responses. They provide essential signals (epitope presentation, proinflammatory cytokines, co-stimulation) to T cells and prime adaptive immunity. Therefore, they are paramount to immunization strategies geared to generate T cell immunity. The inflammatory signals DCs respond to, classically occur in the context of acute virus infection. Yet, enlisting viruses for engaging DCs is hampered by their penchant for targeting DCs with sophisticated immune evasive and suppressive ploys. In this review, we discuss our work on devising vectors based on a recombinant polio:rhinovirus chimera for effectively targeting and engaging DCs. We are juxtaposing this approach with commonly used, recently studied dsDNA virus vector platforms.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • Antigen Presentation / immunology
  • Dendritic Cells / immunology*
  • Dendritic Cells / virology
  • Genetic Vectors*
  • Humans
  • Immune Evasion
  • Immunity, Innate
  • Mice
  • Poliovirus / genetics
  • Poliovirus / immunology
  • T-Lymphocytes / immunology*
  • Viral Tropism*
  • Viral Vaccines / immunology*

Substances

  • Viral Vaccines